Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock

Clinical trial NCT06471231 · UNKNOWN

Trial details

NCT number: NCT06471231
Sponsor: Azienda Usl di Bologna
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Septic Shock Renal Function Replacement

Start date: 2024-05-15
Primary completion: 2026-05-15
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.